Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
Xiaoxiao Xu, Tong Yu, Zhenxing Wang
Topics & Concepts
MedicineAntibody-drug conjugateBreast cancerDrugImmune checkpointAntibodyAntibody therapyImmune systemCancer therapyCancerImmunologyOncologyPharmacologyImmunotherapyCancer researchMonoclonal antibodyInternal medicineHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyMonoclonal and Polyclonal Antibodies Research